The Cortex Innovation Community (Cortex) announced a unique partnership providing access to “core” research facilities located at Saint Louis University (SLU) and Washington University in St. Louis for companies residing in The Center for Emerging Technologies (CET), which is now managed by the Cambridge Innovation Center (CIC@CET).

A total of fourteen core facilities will provide start-up and growing companies at CET@CIC with access to equipment and expertise that are critically important to scaling high-growth bioscience ventures.

“We’re thrilled to deepen our partnerships with our founding partners WashU and SLU by streamlining access to core research facilities that are essential for emerging companies,” said Dennis Lower, president and CEO of Cortex. “It represents a tremendous added value for companies choosing to make CIC@CET home. Startup companies have limited financial resources; having access to sophisticated analytic equipment within a few blocks of their labs preserves cash and can lessen time to market.”

The agreements mark an expansion of available research-related facilities that include cores for mass spectrometry, NMR, flow cytometry, comparative medicine, genomics, protein purification, high throughput screening, microscopy, cell/hybridoma development, GMP production and proteomics. Additionally, contracts to utilize this equipment have been standardized and processes streamlined.

“WashU has invested in numerous core facilities, ensuring that our researchers have access to the latest equipment and technologies,” stated Jenny Lodge, Vice Chancellor for Research at Washington University.  “To offer access to these same facilities and provide the needed technical support to start-up companies in CIC@CET is a valuable extension of our research mission at WashU.”

The largest and oldest innovation center in the State of Missouri, CET is nationally recognized for providing the infrastructure and resources needed for early-stage, high-growth companies in the fields of information technology, bioscience and consumer/manufactured products to innovate and thrive. CET was the launch pad for companies like Exegy, Cardialen, and Stereotaxis and is the home of growing ventures including C2N Diagnostics, Orion Genomics, BacterioScan and EndoStim, among many others.

”SLU is delighted that it can support the start-up community with increased access to its core facilities,” commented Raymond Tait, PhD, Vice President for Research at SLU. “Access to sophisticated facilities and talented SLU faculty certainly can help a start-up to leverage its resources in ways that advance its core technologies more efficiently than would be possible if it were doing the work alone.”

Washington University and SLU are founding partners of Cortex, along with the University of Missouri – St. Louis, BJC HealthCare, and the Missouri Botanical Garden.

Learn more about Cortex.

Related stories in the St. Louis Post-Dispatch, EQ and the St. Louis Business Journal.